-
1
المؤلفون: Martin Haluzik, Peter Novodvorský
المصدر: Expert Opinion on Drug Safety. 21:349-361
مصطلحات موضوعية: Blood Glucose, Insulin degludec, medicine.medical_treatment, Insulin Glargine, Hypoglycemia, Bioinformatics, Glucagon-Like Peptide-1 Receptor, Lixisenatide, chemistry.chemical_compound, Humans, Hypoglycemic Agents, Medicine, Pharmacology (medical), Glucagon-like peptide 1 receptor, Glycated Hemoglobin, business.industry, Liraglutide, Insulin glargine, Insulin, Type 2 Diabetes Mellitus, General Medicine, medicine.disease, Drug Combinations, Diabetes Mellitus, Type 2, chemistry, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da876926bcd9998385782cd25d48c48aTest
https://doi.org/10.1080/14740338.2021.1978974Test -
2
المؤلفون: Yuichiro Yamada, Kenta Murotani, Yusuke Seino, Yutaka Seino, Minori Ishitobi, Yuji Yamazaki, Yuuka Fujiwara, Ryota Usui, Yoshiyuki Hamamoto, Hitoshi Kuwata, Sodai Kubota, Daisuke Yabe, Takeshi Kurose, Takuya Haraguchi, Saki Kubota-Okamoto
المصدر: Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 12, Iss 12, Pp 2162-2171 (2021)مصطلحات موضوعية: Blood Glucose, Male, 0301 basic medicine, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Glucagon-Like Peptides, Gastric emptying, Type 2 diabetes, chemistry.chemical_compound, 0302 clinical medicine, Japan, Insulin, Prospective Studies, digestive, oral, and skin physiology, Articles, General Medicine, Middle Aged, Postprandial Period, Clinical Science and Care, Postprandial, GLP‐1 receptor agonist, Female, Original Article, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Adult, endocrine system, medicine.medical_specialty, Recombinant Fusion Proteins, 030209 endocrinology & metabolism, Gastric Inhibitory Polypeptide, Diseases of the endocrine glands. Clinical endocrinology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, Internal medicine, islet hormones, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Glucagon-like peptide 1 receptor, Liraglutide, business.industry, RC648-665, Glucagon, medicine.disease, Immunoglobulin Fc Fragments, 030104 developmental biology, Endocrinology, Diabetes Mellitus, Type 2, chemistry, Dulaglutide, Apolipoprotein B-48, Peptides, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306175bf3a5c32c1eda622a58314861dTest
https://doi.org/10.1111/jdi.13598Test -
3
المؤلفون: Jennifer Cessario, Zhao Li, Jenny Wahl, Vanessa Pierre-Louis
المصدر: Pharmacological Reports. 73:858-867
مصطلحات موضوعية: Nitric Oxide Synthase Type III, Type 2 diabetes, Pharmacology, Nitric Oxide, medicine.disease_cause, Glucagon-Like Peptide-1 Receptor, Nitric oxide, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Diabetes mellitus, medicine, Empagliflozin, Hyperinsulinemia, Humans, Hypoglycemic Agents, Myocytes, Cardiac, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Cells, Cultured, Cell Death, biology, business.industry, Liraglutide, General Medicine, medicine.disease, Nitric oxide synthase, Oxidative Stress, Diabetes Mellitus, Type 2, chemistry, Cardiovascular Diseases, 030220 oncology & carcinogenesis, biology.protein, business, 030217 neurology & neurosurgery, Oxidative stress, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c815c50a7c4f2ff01746e81915343ee0Test
https://doi.org/10.1007/s43440-021-00224-4Test -
4
المؤلفون: Tatsuya Atsumi, Chiho Oba-Yamamoto, Shin Aoki, Shinji Taneda, Hiraku Kameda, Hideaki Miyoshi, Hiroshi Nomoto, Kyu Yong Cho, Yoshio Kurihara, Jun Takeuchi, Hiroki Yokoyama, Akinobu Nakamura, So Nagai, Yuka Takahashi
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Study Protocol, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Type 2 diabetes mellitus, Internal Medicine, Clinical endpoint, Medicine, Glucagon-like peptide 1 receptor, Glycemic, Treatment satisfaction, business.industry, Liraglutide, Semaglutide, Clinical trial, chemistry, Glucagon-like peptide-1 receptor agonist, Dulaglutide, Glycated hemoglobin, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e36b1c29e0059821e32748eada4dbbTest
https://doi.org/10.1007/s13300-020-00986-9Test -
5
المؤلفون: Benjamin Wolthers, Søren Rasmussen, Vlado Perkovic, Thomas Idorn, John B. Buse, Lawrence A. Leiter, Richard E. Pratley, Tina Vilsbøll, Johannes F.E. Mann
المصدر: Diabetes, Obesity & Metabolism
Mann, J F E, Buse, J B, Idorn, T, Leiter, L A, Pratley, R E, Rasmussen, S, Vilsbøll, T, Wolthers, B & Perkovic, V 2021, ' Potential kidney protection with liraglutide and semaglutide : Exploratory mediation analysis ', Diabetes, Obesity and Metabolism, vol. 23, no. 9, pp. 2058-2066 . https://doi.org/10.1111/dom.14443Testمصطلحات موضوعية: medicine.medical_specialty, kidney mediation, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, glucagon-like peptide-1 receptor agonist, Glucagon-Like Peptides, Renal function, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Kidney, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Internal medicine, glucagon‐like peptide‐1 receptor agonist, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Renal replacement therapy, Creatinine, liraglutide, Mediation Analysis, semaglutide, business.industry, Semaglutide, Original Articles, medicine.disease, Blood pressure, chemistry, Diabetes Mellitus, Type 2, Albuminuria, Original Article, type 2 diabetes, medicine.symptom, business, chronic kidney disease, Kidney disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8977c898c125452c9a079b84a9fc59Test
https://pubmed.ncbi.nlm.nih.gov/34009708Test -
6
المؤلفون: Mervete Miftaraj, Stefan Franzén, Björn Eliasson, Anders Toll, Jeremie Lebrec, Ann-Marie Svensson
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, Glucagon-Like Peptides, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, GLP‐1 analogue, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, education, Retrospective Studies, Sweden, antidiabetic drug, education.field_of_study, population study, Liraglutide, business.industry, Original Articles, medicine.disease, Discontinuation, Diabetes Mellitus, Type 2, chemistry, Propensity score matching, Original Article, Dulaglutide, type 2 diabetes, business, Exenatide, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aeac7d5bfcd2c99670139bdc98ad5b5Test
https://doi.org/10.1111/dom.14276Test -
7
المؤلفون: Christopher K. Rayner, Alka Shaunik, Steve Kanters, Patricia Guyot, Vanita R. Aroda, Tongzhi Wu, Michael Horowitz, Craig Whittington
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: medicine.medical_specialty, Nausea, Endocrinology, Diabetes and Metabolism, Network Meta-Analysis, Insulin Glargine, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Gastroenterology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Adverse effect, Glycated Hemoglobin, Liraglutide, business.industry, Semaglutide, Bayes Theorem, Original Articles, medicine.disease, chemistry, Diabetes Mellitus, Type 2, Dulaglutide, Original Article, medicine.symptom, business, Peptides, Exenatide, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7d3d1a65a9dd5d2c1f4bf6d0bbd9db6Test
http://europepmc.org/articles/PMC7756611Test -
8
المؤلفون: Hai Qian, Chunxia Liu, Yuxing Zou
المصدر: Expert Opinion on Therapeutic Patents. 30:781-794
مصطلحات موضوعية: endocrine system, medicine.medical_specialty, medicine.medical_treatment, Glucagon-Like Peptides, Peptide, Endogeny, Enteroendocrine cell, 01 natural sciences, Glucagon, Glucagon-Like Peptide-1 Receptor, Patents as Topic, 03 medical and health sciences, 0302 clinical medicine, Glucagon-Like Peptide 1, Internal medicine, Drug Discovery, medicine, Animals, Humans, Obesity, Receptor, Pharmacology, chemistry.chemical_classification, Insulin, digestive, oral, and skin physiology, General Medicine, Liraglutide, medicine.disease, 0104 chemical sciences, 010404 medicinal & biomolecular chemistry, Endocrinology, chemistry, 030220 oncology & carcinogenesis, Glucose-dependent insulinotropic polypeptide, Anti-Obesity Agents, Peptides, hormones, hormone substitutes, and hormone antagonists
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3afe6c00ed95b9c0aebc29e6077897d7Test
https://doi.org/10.1080/13543776.2020.1811851Test -
9
المؤلفون: Ryusuke Koshida, Hideaki Kaneto, Mike Baxter
المصدر: Diabetes, Obesity and Metabolism. 22:24-34
مصطلحات موضوعية: Insulin degludec, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin Glargine, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Japan, Internal Medicine, medicine, Humans, Hypoglycemic Agents, business.industry, Insulin glargine, Liraglutide, Insulin, medicine.disease, Glucagon-like peptide-1, Postprandial, Diabetes Mellitus, Type 2, chemistry, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa2cd866b44b4c6bf368f94c614d83dTest
https://doi.org/10.1111/dom.14095Test -
10
المؤلفون: Jakob Wefers, Juris J. Meier, Michael A. Nauck, Daniel R. Quast
المصدر: Molecular Metabolism, Vol 46, Iss, Pp 101102-(2021)
Molecular Metabolismمصطلحات موضوعية: Blood Glucose, 0301 basic medicine, Glucagon-Like Peptides, Review, Type 2 diabetes, Pharmacology, Cardiovascular System, chemistry.chemical_compound, 0302 clinical medicine, Glucagon-Like Peptide 1, Insulin, Neurodegenerative Diseases, Cardiovascular disease, Albiglutide, medicine.drug, lcsh:Internal medicine, Recombinant Fusion Proteins, Lixisenatide, 030209 endocrinology & metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-like peptide-1 receptor agonists, 03 medical and health sciences, medicine, Animals, Humans, Psoriasis, Dulaglutide, lcsh:RC31-1245, Molecular Biology, Gastric emptying, Liraglutide, business.industry, Semaglutide, Body Weight, Cell Biology, medicine.disease, Hypoglycemia, Immunoglobulin Fc Fragments, 030104 developmental biology, Diabetes Mellitus, Type 2, chemistry, Exenatide, Peptides, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875775b98729f2e1bb80ab140f2751b8Test
http://www.sciencedirect.com/science/article/pii/S2212877820301769Test
